Interpretation of Farnesoid X Receptor Immunohistochemical Expression in Discriminating Hepatocellular Carcinoma from Its Non-Neoplastic Mimics as an Adjunct to Glypican 3.
Doaa E A SalamaLobna Sadek ShashMarwa Mosaad ShakweerRania Rifat Abdel-MaqsoudAmany Ibrahim Ahmed AbosaifShimaa Abdelraouf ElgoharyPublished in: Asian Pacific journal of cancer prevention : APJCP (2023)
The present work revealed that FXR could be combined with GPC3 in distinguishing between HCC and non-neoplastic hepatic lesions with improved specificity rather than using an individual marker.